Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab With Platinum and Etoposide Followed by Cystectomy for Localized Small Cell Bladder Cancer
NCT05312671Phase 2Recruiting
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jun 2022
- Primary completion
- Oct 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab in small cell neuroendocrine carcinoma of the bladder (SCCB), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Jun 2022; status: recruiting.
02
Drugs
atezolizumab
03
Conditions
small cell neuroendocrine carcinoma of the bladder (SCCB)
Beyond the preview
Go deeper on NCT05312671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05312671.